We are live on ! Find out more
EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares

Delisted

EBAC was delisted on the 2nd of March, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$6.05M +$4.54K +469 +0.1%
Macquarie Group
2
Macquarie Group
Australia
$4.87M +$4.87M +504,000 New
LA
3
Linden Advisors
New York
$4.84M
Marshall Wace
4
Marshall Wace
United Kingdom
$3.15M
ACA
5
Arena Capital Advisors
California
$2.93M +$2.18M +225,899 +301%
SCM
6
Suvretta Capital Management
New York
$2.9M
WP
7
Woodline Partners
California
$2.67M
MI
8
MMCAP International
Cayman Islands
$2.42M
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$2.21M +$1.89M +195,697 +587%
RCM
10
Radcliffe Capital Management
Pennsylvania
$1.95M
SC
11
Sculptor Capital
New York
$1.93M
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$1.45M
FTCM
13
Fir Tree Capital Management
New York
$1.45M
AC
14
Athanor Capital
New York
$1.43M
Millennium Management
15
Millennium Management
New York
$1.26M -$183K -18,900 -13%
PMAM
16
Picton Mahoney Asset Management
Ontario, Canada
$1.22M
GCM
17
Ghisallo Capital Management
Massachusetts
$1.21M
MCM
18
Moore Capital Management
New York
$1.21M
DCM
19
Dupont Capital Management
Delaware
$971K
AA
20
AQR Arbitrage
Connecticut
$969K +$544K +56,210 +128%
Hudson Bay Capital Management
21
Hudson Bay Capital Management
Connecticut
$967K
TCM
22
Tenor Capital Management
New York
$967K
CCM
23
CAAS Capital Management
New York
$935K +$935K +96,710 New
GF
24
Gabelli Funds
New York
$711K +$709K +73,303 New
GCIA
25
Gabelli & Co Investment Advisers
New York
$637K +$635K +65,689 New